To further investigate the association between DPP10-AS1 expression and clinicopathological characteristics, we divided 94 lung cancer samples into 2 subgroups according to the median relative DPP10-AS1 expression ratio: a high DPP10-AS1 group (n = 47, DPP10-AS1 ratio ≥ median ratio) and a low DPP10-AS1 group (n = 47, DPP10-AS1 ratio < median ratio). This evidence concerns the gene DPP10 and lung carcinoma.